Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma

被引:0
|
作者
Kenneth F. Koral
John P. Huberty
Bill Frame
Katherine K. Matthay
John M. Maris
Denise Regan
Daniel Normolle
Gregory A. Yanik
机构
[1] University of Michigan,Department of Radiology, Nuclear Medicine Division
[2] University of California San Francisco,Department of Nuclear Medicine
[3] University of Michigan Comprehensive Cancer Center,Biostatistics Unit
[4] University of California San Francisco,Department of Pediatrics
[5] Children’s Hospital of Philadelphia,Department of Pediatrics
[6] University of Michigan,Department of Radiation Oncology
[7] University of Michigan,Department of Pediatrics
关键词
Dosimetry; Liver disease; Radionuclide therapy; Iodine-131; MIBG neuroblastoma oncology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2105 / 2112
页数:7
相关论文
共 50 条
  • [41] I-131 MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Gedik, G. K.
    Hoefnagel, C. A.
    Bais, E.
    Olmos, R. A. Valdes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S241 - S241
  • [42] Dosimetry for Repeated 131I-mIBG Therapy of Phaeochromoblastoma
    Happel, C.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Plastowez, W.
    Diener, J.
    Kranert, W. T.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [43] Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
    DuBois, Steven G.
    Groshen, Susan
    Park, Julie R.
    Haas-Kogan, Daphne A.
    Yang, Xiaodong
    Geier, Ethan
    Chen, Eugene
    Giacomini, Kathy
    Weiss, Brian
    Cohn, Susan L.
    Granger, M. Meaghan
    Yanik, Gregory A.
    Hawkins, Randall
    Courtier, Jesse
    Jackson, Hollie
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Czarnecki, Scarlett
    Tsao-Wei, Denice
    Villablanca, Judith G.
    Marachelian, Araz
    Matthay, Katherine K.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2715 - 2721
  • [44] Personalized dosimetry for a deeper understanding of metastatic response to high activity 131I-mIBG therapy in high risk relapsed refractory neuroblastoma
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Valeri, Silvio
    Polito, Claudia
    Donatiello, Salvatore
    Altini, Claudio
    Villani, Maria Felicia
    Serra, Annalisa
    Castellano, Aurora
    Garganese, Maria Carmen
    Cannata, Vittorio
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (02) : 1299 - 1310
  • [45] DOSIMETRY FOR I-131 META-IODOBENZYLGUANIDINE-THERAPY
    KIMMIG, B
    ADOLPH, J
    NUKLEARMEDIZINER, 1987, 10 (04): : 307 - 316
  • [46] PRIMARY HYPOTHYROIDISM AND I-131 METAIODOBENZYLGUANIDINE THERAPY IN NEUROBLASTOMA
    PICCO, P
    GARAVENTA, A
    CLAUDIANI, F
    GARIBALDI, L
    BORRONE, C
    LANCET, 1993, 342 (8862): : 57 - 57
  • [47] Integrated Dosimetry Software for Azedra I-131 Therapy
    Sheftman, D.
    Hintenlang, D.
    MEDICAL PHYSICS, 2022, 49 (06) : E656 - E657
  • [48] Comparison of tracer-based, weight-based and standard therapy administration for I-131 MIBG therapy of neuroblastoma
    Flux, GD
    Chittenden, SC
    Pomeroy, KM
    Guy, MJ
    Flower, MA
    Meller, ST
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1040 - 1040
  • [49] High dose dosimetry-guided 131I-MIBG treatment for refractory primary neuroblastoma: a case report
    Boni, G.
    Borso, E.
    Mazzarri, S.
    Menconi, M.
    Casazza, G.
    Favre, C.
    Traino, C. A.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [50] Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
    Buckley, Susan E.
    Chittenden, Sarah J.
    Saran, Frank H.
    Meller, Simon T.
    Flux, Glenn D.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (09) : 1518 - 1524